Want to see HK:2192 full AI Analyst Report?
Total Valuation
Medlive Technology Co., Ltd. has a market cap or net worth of HK$4.76B. The enterprise value is HK$2.03B.
Market CapHK$4.76B
Enterprise ValueHK$2.03B
Share Statistics
Medlive Technology Co., Ltd. has 740,274,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding740,274,500
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medlive Technology Co., Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 1.79%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)1.79%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee900.64K
Profits Per Employee505.31K
Employee Count713
Asset Turnover0.12
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medlive Technology Co., Ltd. is 11.9. Medlive Technology Co., Ltd.’s PEG ratio is 4.16.
PE Ratio11.9
PS Ratio10.00
PB Ratio1.32
Price to FCF52.74
Price to Operating Cash Flow14.26
PEG Ratio4.16
Income Statement
In the last 12 months, Medlive Technology Co., Ltd. had revenue of 642.15M and earned 334.34M in profits. Earnings per share was 0.45.
Revenue642.15M
Gross Profit385.44M
Operating Income91.87M
Pretax Income360.29M
Net Income334.34M
EBITDA188.44M
Earnings Per Share (EPS)0.45
Cash Flow
In the last 12 months, operating cash flow was 273.45M and capital expenditures -2.12M, giving a free cash flow of 271.32M billion.
Operating Cash Flow273.45M
Free Cash Flow271.32M
Free Cash Flow per Share0.37
Dividends & Yields
Medlive Technology Co., Ltd. pays an annual dividend of HK$0.151, resulting in a dividend yield of 4.89%
Dividend Per ShareHK$0.151
Dividend Yield4.89%
Payout Ratio60.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.39
52-Week Price Change-43.22%
50-Day Moving Average7.02
200-Day Moving Average8.08
Relative Strength Index (RSI)38.04
Average Volume (3m)642.85K
Important Dates
Medlive Technology Co., Ltd. upcoming earnings date is Mar 29, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateMar 29, 2027
Ex-Dividend Date―
Financial Position
Medlive Technology Co., Ltd. as a current ratio of 19.09, with Debt / Equity ratio of 0.13%
Current Ratio19.09
Quick Ratio19.09
Debt to Market Cap0.00
Net Debt to EBITDA-13.57
Interest Coverage Ratio166.44
Taxes
In the past 12 months, Medlive Technology Co., Ltd. has paid 12.40M in taxes.
Income Tax12.40M
Effective Tax Rate0.03
Enterprise Valuation
Medlive Technology Co., Ltd. EV to EBITDA ratio is 20.49, with an EV/FCF ratio of 31.72.
EV to Sales6.01
EV to EBITDA20.49
EV to Free Cash Flow31.72
EV to Operating Cash Flow28.70
Balance Sheet
Medlive Technology Co., Ltd. has HK$2.66B in cash and marketable securities with HK$6.43M in debt, giving a net cash position of HK$2.66B billion.
Cash & Marketable SecuritiesHK$2.66B
Total DebtHK$6.43M
Net CashHK$2.66B
Net Cash Per ShareHK$3.59
Tangible Book Value Per ShareHK$6.34
Margins
Gross margin is 61.31%, with operating margin of 14.31%, and net profit margin of 52.07%.
Gross Margin61.31%
Operating Margin14.31%
Pretax Margin56.11%
Net Profit Margin52.07%
EBITDA Margin29.35%
EBIT Margin26.06%
Analyst Forecast
The average price target for Medlive Technology Co., Ltd. is HK$9.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetHK$9.75
Price Target Upside27.12% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast6.47%
EPS Growth Forecast8.10%